Cargando…
Application of RNAi to Genomic Drug Target Validation in Schistosomes
Concerns over the possibility of resistance developing to praziquantel (PZQ), has stimulated efforts to develop new drugs for schistosomiasis. In addition to the development of improved whole organism screens, the success of RNA interference (RNAi) in schistosomes offers great promise for the identi...
Autores principales: | Guidi, Alessandra, Mansour, Nuha R., Paveley, Ross A., Carruthers, Ian M., Besnard, Jérémy, Hopkins, Andrew L., Gilbert, Ian H., Bickle, Quentin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438872/ https://www.ncbi.nlm.nih.gov/pubmed/25992548 http://dx.doi.org/10.1371/journal.pntd.0003801 |
Ejemplares similares
-
Comparison of Microscopy and Alamar Blue Reduction in a Larval Based Assay for Schistosome Drug Screening
por: Mansour, Nuha R., et al.
Publicado: (2010) -
Whole Organism High-Content Screening by Label-Free, Image-Based Bayesian Classification for Parasitic Diseases
por: Paveley, Ross A., et al.
Publicado: (2012) -
High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni
por: Mansour, Nuha R., et al.
Publicado: (2016) -
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species
por: Gardner, J. Mark F., et al.
Publicado: (2021) -
CD4(+)CD25(+) Regulatory Cells Contribute to the Regulation of Colonic Th2 Granulomatous Pathology Caused by Schistosome Infection
por: Turner, Joseph D., et al.
Publicado: (2011)